Its mechanism of action involves competing with CD28 to bind to CD80/CD86. CD28 is required for the full activation of T cells through binding of CD80/86 on the antigen-presenting cell ...
The research team found an increasing number of the surface proteins CD80 and CD86 in the tumor cells. Such a high number of these proteins is not found in healthy B lymphocytes (B cells), the ...